Jan Haavik is a medical doctor who graduated from the University of Bergen. After completion of an 18 month clinical internship in internal medicine, surgery and general practice, he started research in biochemistry, biophysics and molecular biology. He defended his dr. med./phd degree in biochemistry in 1989 and was appointed as full professor at Department of Biochemistry and Molecular Biology in 1993. During his entire career he has combined teaching, basic and translational neuroscience research with full-time or part-time clinical duties. He is a board certified specialist of adult psychiatry. From 2002 he has been working a senior consultant in psychiatry at Haukeland University hospital, with a special focus on ADHD and affective disorders. He is leading the Neurotargeting Research group and the Center of Neuropsychiatric Disorders, dedicated to exploring new treatment targets for neuropsychiatric disorders. He is involved in multiple international collaborative projects. Interspersed with his work in Norway, he has had multiple stays research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands.
- 2019. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites. Brain Stimulation. 1-8. doi: 10.1016/j.brs.2019.05.018
- 2019. Individual Variability in Reaction Time and Prediction of Clinical Response to Methylphenidate in Adult ADHD: A Prospective Open Label Study Using Conners’ Continuous Performance Test II. Journal of Attention Disorders. doi: 10.1177/1087054719829822
- 2019. Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry. 176: 531-542. doi: 10.1176/appi.ajp.2019.18091033
- 2019. Nordic OCD & Related Disorders Consortium: Rationale, design, and methods. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 1-13. doi: 10.1002/ajmg.b.32756
- 2019. Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry. 46 pages. doi: 10.1016/j.biopsych.2019.04.021
- 2019. Effect of disease-associated SLC9A9 mutations on protein–protein interaction networks: implications for molecular mechanisms for ADHD and autism. ADHD Attention Deficit and Hyperactivity Disorders. 11: 91-105. doi: 10.1007/s12402-018-0281-x
- 2018. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics. 51: 63-75. doi: 10.1038/s41588-018-0269-7
- 2018. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. European Neuropsychopharmacology. 28: 1059-1088. doi: 10.1016/j.euroneuro.2018.08.001
- 2018. Moderating effect of mode of delivery on the genetics of intelligence: Explorative genome-wide analyses in ALSPAC. Brain and Behavior. 1-12. doi: 10.1002/brb3.1144
- 2018. The quaternary structure of human tyrosine hydroxylase: effects of dystonia‐associated missense variants on oligomeric state and enzyme activity. Journal of Neurochemistry. 148: 291-306. doi: 10.1111/jnc.14624
Jan Haavik completed his medical education at the University of Bergen in 1983. As a student, he started his research career in biochemistry, biophysics and molecular biology. He conducted a tour of Bergen and the municipalities of Agder, graduated from the University of Bergen in 1989, and was employed as a professor, 34, at the present Institute of Biomedicine in 1993. In the period 1986-2014 he had nine shorter and longer research stays at outstanding research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands. From 2002 he has had a 20% position as a general practitioner in psychiatry, first at Øyane DPS and later at Kronstad DPS, both affiliated with Helse Bergen.